Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00214279
Status:
COMPLETED
Last Update Posted:
2012-06-26
First Post:
2005-09-14
Brief Title:
MMF Monotherapy and Immune Regulation in Kidney Transplant Recipients Part 1 Steroid Withdrawal
Sponsor:
University of Wisconsin Madison
Organization:
University of Wisconsin Madison
Study Overview
Official Title:
MMF Monotherapy and Immune Regulation in Kidney Transplant Recipients Part 1 Steroid Withdrawal
Status:
COMPLETED
Status Verified Date:
2012-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Part 1 of the study is to gradually withdraw steroids in a group of 50 older renal transplant recipients converting then from the 3 drug regimen to a 2 drug regimen cyclosporine and MMF while carefully monitoring their graft function 25 subjects would serve as control patients in the study and would remain on the 3 drug regimen steroids cyclosporine and MMF Immunologic status will be determined before and after IS withdrawal using a delayed-type hypersensitivity DTH transfer test previously described in the original submission Both the steroid withdrawal subjects and the control subjects will undergo the DTH testing throughout the 3 years of study participation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| CEL340 | None | None | None |